Reading Room Production — page 114

] ool ] ool OLPA plans to include the nay be asked to review Please let me know if you have any questions. el 6 PM [AID DEA DART NIAID) [E] NIAID) [E] VIH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] ay >; (NIH/NIAID) [E] I NIH/NIAID) [E] iy NIAID) [E] ) 5 AM [AID DEA DART NIAID) [2] i NIAID) [E] VIH/NIAID) [E] i NIH/NIAID) [E] VIH/NIAID) [] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] Please review the attached draft HHS comments on the Risky Research Review Act and provide your concurrence, or any edits, by COB today, Tuesday July 16th. If you have any concerns with OCGR-Leg's proposed edit to the comment on page 9, please let us know. Please note that NIH OLPA is also working on a separate request from the Senate Health, Education, Labor, and Pensions (HELP) Committee (Chair: Sen. Bernie Sanders, I-VT) for technical assistance on this bill. OLPA plans to include the specific NIAID comments shared yesterday in this separate request. We anticipate we may be asked to review consolidated NIH comments for the HELP Committee this week. Thank you for your ongoing assistance with reviewing this bill. Please let me know if you have any questions. Thanks, Sara From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Monday, July 15, 2024 12:26 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: Additional OSP comments: TA on Risky Research Review Act Hello all, For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as we have them. Please let me know if you have any questions. Thanks, Sara From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Monday, July 15, 2024 10:35 AM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: For review by noon Monday 7/15: Review draft NIAID TA on Risky Research Review Act Importance: High Hello all,